NCT00866385View on ClinicalTrials.gov

AZD8566 Food Effect/Microtracer Study

PHASE1CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

March 31, 2009

Study Completion Date

April 30, 2009

Conditions

Healthy Volunteer Study

Interventions

DRUG

AZD8566

Single 6 mg oral solution dose

DRUG

AZD8566 IV carbon labelled

Single 10 mcg intravenous carbon-14 microtracer dose

Trial Locations (1)

Unknown

Research Site, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY